Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID | D01VFQ | ||||
| Former ID | DIB009523 | ||||
| Drug Name | CGEN-855 | ||||
| Synonyms | CGEN-855; CGEN-855A; CGEN-855B; FPRL1 G-protein-coupled receptor agonists (peptide, inflammation/cardiac disorder); FPRL1 G-protein-coupled receptor agonists (peptide, inflammation/cardiac disorder), Compugen | ||||
| Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Investigative | [541409] | ||
| Company | Compugen Ltd | ||||
| Target and Pathway | |||||
| Target(s) | FMLP receptor | Target Info | Agonist | [543577] | |
| NetPath Pathway | Leptin Signaling Pathway | ||||
| Pathway Interaction Database | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | ||||
| Reactome | G alpha (i) signalling events | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.
